BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

GREAT VALLEY ADVISOR GROUP, INC.'s Holding History (CIK: 0001769897)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 16,400 Value ($000) $125 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 16,400 Value ($000) $101 Avg Close $5.52 Range $4.03 - $6.99

Q1 2024

Shares 17,400 Value ($000) $88 Avg Close $5.62 Range $4.82 - $7.75

Q4 2023

Shares 16,300 Value ($000) $98 Avg Close $5.79 Range $4.83 - $7.06

Q3 2023

Shares 16,300 Value ($000) $115 Avg Close $7.18 Range $6.62 - $7.95

Q2 2023

Shares 12,100 Value ($000) $85 Avg Close $8.02 Range $6.87 - $9.07

Q1 2023

Shares 10,300 Value ($000) $86 Avg Close $9.63 Range $7.82 - $12.08

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	16,400	$125	$7.60	$6.17 - $8.88
Q2 2024	16,400	$101	$5.52	$4.03 - $6.99
Q1 2024	17,400	$88	$5.62	$4.82 - $7.75
Q4 2023	16,300	$98	$5.79	$4.83 - $7.06
Q3 2023	16,300	$115	$7.18	$6.62 - $7.95
Q2 2023	12,100	$85	$8.02	$6.87 - $9.07
Q1 2023	10,300	$86	$9.63	$7.82 - $12.08